rare diseases

My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
Commentary

My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup

By
March 10, 2025
Céline Dion says she may never tour again amid battle with stiff person syndrome. Here’s what to know
Health

Céline Dion says she may never tour again amid battle with stiff person syndrome. Here’s what to know

By Alexa Mikhail and Jordyn Bradley
April 23, 2024
‘Desperate for answers’: Thousands of people finally received diagnoses that had eluded them for years. Here’s how
Health

‘Desperate for answers’: Thousands of people finally received diagnoses that had eluded them for years. Here’s how

By
April 14, 2023
It takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?
Health

It takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?

By
February 28, 2023
Mother holds child's hand
Health

Parents are becoming drug developers to find a cure for their children’s rare diseases

By Jared Whitlock and Kaiser Health News
July 21, 2022
Girl (8-9) smiling behind a pink protective face mask
Health

Long COVID in kids is worrying the experts: ‘It affects everybody differently and at different timescales’

By
October 20, 2021
Cures for many rare diseases might already exist. Why aren’t we using them?
Commentary

Cures for many rare diseases might already exist. Why aren’t we using them?

By
July 5, 2021
COVID forgotten communities
Newsletters

The communities we forget during COVID-19

By
April 30, 2020
The coronavirus pandemic is impacting critical research into neuromuscular diseases
Health

The coronavirus pandemic is impacting critical research into neuromuscular diseases

By
April 28, 2020
An FDA Program Incentivizing Rare Disease Drugs Will Be Investigated for Abuses
Health

An FDA Program Incentivizing Rare Disease Drugs Will Be Investigated for Abuses

By
March 22, 2017
Martin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices
Health

Martin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices

By
July 1, 2016
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
International

Shire switches from target to predator with $5.2 billion NPS buy

By
January 12, 2015

Most Popular